07:17 AM EDT, 08/04/2025 (MT Newswires) -- Krystal Biotech ( KRYS ) reported Q2 earnings Monday of $1.29 per diluted share, up from $0.53 a year earlier.

Two analysts polled by FactSet expected $1.

Net product revenue for the quarter ended June 30 was $96 million, compared with $70.3 million a year earlier.

Analysts surveyed by FactSet expected $92 million.

Shares of the company were up 7.7% in recent premarket activity Monday.